Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Megestrol acetate in cachexia and anorexia.

Shing-Shing Yeh1, Michael W Schuster

  • 1Northport VAMC, Geriatric division, Northport, NY 11768, USA. shingshing.yeh@med.va.gov

International Journal of Nanomedicine
|August 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Burixafor, a CXCR4 inhibitor with a differentiated kinetics profile: results of a phase 2 study for rapid cell mobilization in multiple myeloma and lymphoma patients undergoing transplant.

Annals of hematology·2026
Same author

Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients.

Blood advances·2024
Same author

Illness Uncertainties Tied to Developmental Tasks Among Young Adult Survivors of Hematologic Cancers.

Journal of adolescent and young adult oncology·2018
Same author

A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia.

American journal of hematology·2017
Same author

Effect of cord blood processing on transplantation outcomes after single myeloablative umbilical cord blood transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2014
Same author

JAAD grand rounds quiz. Bullae and nodules on the legs of a 57-year-old woman.

Journal of the American Academy of Dermatology·2014

This review examines clinical trials on megestrol acetate (MA) for treating cachexia. It discusses MA

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Cachexia is a complex metabolic syndrome characterized by involuntary weight loss and muscle wasting, frequently associated with chronic diseases.
  • Megestrol acetate (MA) is a synthetic progestogen with appetite-stimulating properties, historically used in managing cachexia.
  • Optimizing drug delivery systems may enhance therapeutic efficacy for medications like MA.

Purpose of the Study:

  • To review pivotal clinical trials investigating megestrol acetate (MA) for cachexia treatment across diverse pathologies.
  • To provide an overview of MA's general clinical applications and documented adverse effects.
  • To explore the potential benefits of novel nanocrystal formulations of MA for improved drug delivery and therapeutic outcomes.

Main Methods:

Related Experiment Videos

  • Systematic literature search of major clinical trials involving megestrol acetate in cachexia.
  • Review of pharmacological data and clinical usage guidelines for megestrol acetate.
  • Analysis of emerging research on nanocrystal drug delivery systems for megestrol acetate.

Main Results:

  • Megestrol acetate has demonstrated efficacy in improving appetite and promoting weight gain in cachectic patients.
  • Common side effects include weight gain, thromboembolic events, and adrenal insufficiency.
  • Nanocrystal formulations may offer enhanced bioavailability and potentially improved clinical response compared to conventional MA preparations.

Conclusions:

  • Megestrol acetate remains a viable option for managing cachexia, balancing benefits against potential risks.
  • Further research into nanocrystal MA formulations is warranted to confirm enhanced efficacy and safety profiles.
  • Personalized treatment approaches considering disease state and patient factors are crucial for optimizing MA therapy in cachexia.